Please use this identifier to cite or link to this item: http://dl.umsu.ac.ir/handle/Hannan/75662
Title: Which Variables Are Useful for Predicting Severe Infection in Children With Febrile Neutropenia?
Authors: Mathilde Delebarre;Nathalie Garnier;Emilie Macher;Estelle Thebaud;Franc¸oise Mazingue;Pierre Leblond;Alain Duhamel
subject: fever, neutropenia, cancer, children, predictive variable
Year: 2015
Abstract: To distinguish children with chemotherapy-induced febrile neutropenia (FN) at low risk of severe infection, the variables that are significant risk factors must be identified. Our objective was to identify them by applying evidence-based standards. This retrospective 2-center cohort study included all episodes of chemotherapy-induced FN in children in 2005 and 2006. The medical history, clinical, and laboratory data available at admission were collected. Severe infection was defined by bacteremia, a positive culture of a normally sterile body fluid, invasive fungal infection, or localized infection at high risk of extension. Univariate analysis identified potential predictive variables. A generalized mixed model was used to determine the adjusted variables that predict severe infection. We analyzed 372 FN episodes. Severe infections occurred in 16.1% of them. Variables predictive of severe infection at admission were: disease with high risk of prolonged neutropenia (adjusted odds ratio [aOR]=2.5), blood cancer (aOR=1.9), fever Z38.51C (aOR=3.7), and C-reactive protein level Z90 mg/L (aOR=4.5). Now that we have identified these variables significantly associated with the risk of severe infection, they must be validated prospectively before combining the best predictive variables in a decision rule that can be used to distinguish children at low risk.
URI: http://dl.umsu.ac.ir/handle/Hannan/75662
Appears in Collections:Journal of pediatric hematology oncology 2015

Files in This Item:
File Description SizeFormat 
e468.pdf186.97 kBAdobe PDFThumbnail
Download    Request a copy


Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.